Information Provided By: 
Fly News Breaks for April 30, 2015
HOLX
Apr 30, 2015 | 07:51 EDT
UBS said the turn-around at Hologic is intact as adoption of its 3D Tomo instrument placements has accelerated. The firm said comps will get harder but with an overhaul of senior leadership, a pay down of debt, and an improved operational outlook, its buy thesis remains intact. UBS reiterated its Buy rating and $38 price target on Hologic shares.
News For HOLX From the Last 2 Days
There are no results for your query HOLX
